What to know about variable heart rhythms and AFib
An Ohio State cardiac electrophysiologist shares what to know about heart rhythms and AFib.
The Ohio State University's Dorothy M. Davis Heart and Lung Research Institute (DHLRI) is one of the nation’s few free-standing facilities devoted entirely to the research of diseases affecting the heart, lungs and blood vessels.
Researchers at the DHLRI work closely with clinicians at Ohio State's Ross Heart Hospital to translate their findings into new procedures and medical therapies for patients with heart and vascular disease in the areas of:
For information about enrolling in clinical trials at Ohio State’s Ross Heart Hospital, call the Heart and Vascular Research Unit (HVRO) or contact email@example.com. You can also review current research studies at Ohio State and register to become a participant at our Participate in Research Studies page.
Ohio State's heart and vascular experts are hoping to extend the lives of those living with this rare and deadly disease.
Ohio State was one of the first in the country to implant a tiny, high-tech pacemaker, only 24 millimeters long, directly into the heart of patients, without surgery.
Ohio State led the national study of a new heart failure monitoring device and was the first in the nation to use the device in patients after it received FDA approval.
Dr. Mohler, a prominent medical researcher, earned a doctorate in molecular physiology in 2000 at the University of North Carolina at Chapel Hill and completed a post-doctoral fellowship in 2004 at the Howard Hughes Medical Institute at Duke University. He was named a Pew Scholar by the Pew Charitable Trusts in 2007 and a Kavli Scholar of the U.S. National Academy of Sciences in 2009. His research program focuses on solving the pathways underlying such conditions as cardiac arrhythmia, diabetes and neurological dysfunction.
Get tips from Ohio State experts right to your inbox.